Discontinuation of Anti-Tumour Necrosis Factor Alpha Treatment Owing to Blood Test Abnormalities, and Cost-Effectiveness of Alternate Blood Monitoring Strategies.
BRITISH JOURNAL OF DERMATOLOGY（2024）
Key words
Disease-Modifying Antirheumatic Drugs
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined